EUVIMEDEUVIMED entdecken
Open Access

Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility

Yi-Ting Yang, Bin Yan, Yu-Hua Li, Li-Na Guo, Wei-Wei Wang, Li-Jie Liu, He-Guo Yu, Hua Diao

Asian Journal of Andrology · 2023

DOI: 10.4103/aja2022117 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Asian Journal of Andrology, 2023. Verfasst von Yi-Ting Yang und 7 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), School of Basic Medical Sciences, …. Hauptthemen laut MEDLINE: Sperm Motility, Sildenafil Citrate, Spermatozoa, Phosphodiesterase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phosphodiesterase (PDE) inhibitors can improve sperm motility in patients with asthenozoospermia. However, the most commonly reported nonselective PDE inhibitor pentoxifylline and PDE5 inhibitor sildenafil have the disadvantages of requiring a high concentration and destroying sperm integrity. We examined the PDE10A inhibitor PF-2545920 to compare its ability to promote sperm motility with that of pentoxifylline and sildenafil. After seminal plasma was discarded, several semen samples were subjected to four treatments (control, PF-2545920, pentoxifylline, and sildenafil) to evaluate their ability to affect motility, viability, and spontaneous acrosome reactions. Intracellular calcium and adenosine triphosphate (ATP), mitochondrial membrane potential, and penetration through viscous medium were assessed by flow cytometry, luciferase, and hyaluronic acid after treatment with PF-2545920. Statistical analyses were performed using the analysis of variance statistical test. PF-2545920 elevated the percentage of motile spermatozoa compared to the control, pentoxifylline, and sildenafil groups at 10 µmol l −1 ( P < 0.01). It is less toxic to GC-2spd mouse spermatocytes cells and spermatozoa and causes fewer spontaneous acrosomal reactions ( P < 0.05). PF-2545920 also increased mitochondrial membrane potential ( P < 0.001) and altered intracellular calcium ( P < 0.05) in a dose-dependent manner, including increasing sperm hyaluronic acid penetrating ability ( P < 0.05). Therefore, PF-2545920 might be an excellent choice for stimulating the sperm motility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sperm MotilitySildenafil CitrateSpermatozoaPhosphodiesterase InhibitorsMembrane Potential, MitochondrialMaleHumansAnimalsMicePentoxifyllineAcrosome ReactionAsthenozoospermiaAdenosine TriphosphateCalcium

Substanzen

Sildenafil CitratePhosphodiesterase InhibitorsPentoxifyllineAdenosine TriphosphateCalcium

Autor:innen und Institutionen

  • NHC Key Laboratory of Reproduction Regulation (Shanghai Institute for Biomedical and Pharmaceutical Technologies), School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • Reproductive Medicine Centre, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
  • School of Basic Medical Sciences, Fudan University, Shanghai 200032, China.
  • Department of Urology, Huashan Hospital, Fudan University, Shanghai 200040, China.

Zitieren

APA

Yang, Y. T., Yan, B., Li, Y. H., Guo, L. N., Wang, W. W., Liu, L. J., Yu, H. G., & Diao, H. (2023). Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility. Asian Journal of Andrology. https://doi.org/10.4103/aja2022117

Vancouver

Yang YT, Yan B, Li YH, Guo LN, Wang WW, Liu LJ, et al. Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility. Asian Journal of Andrology. 2023. doi:10.4103/aja2022117

BibTeX
@article{Yang2023,
  author = {Yang, Yi-Ting and Yan, Bin and Li, Yu-Hua and Guo, Li-Na and Wang, Wei-Wei and Liu, Li-Jie and Yu, He-Guo and Diao, Hua},
  title = {Phosphodiesterase 10A inhibitor PF-2545920 as a prospective agent for the clinical promotion of sperm motility},
  journal = {Asian Journal of Andrology},
  year = {2023},
  doi = {10.4103/aja2022117}
}
Kostenlos starten →